The Office for Health Improvements and Disparities (OHID) has recently published updates to its Respiratory Disease Profile, including new data on hospital admissions and mortality.
Hospital admissions
Data on emergency hospital admissions and the percentages of zero- and one-day admissions for the financial year ending 2025 have been added to the profile.
The following indicators have been updated, showing emergency hospital admissions data for:
- respiratory disease
- chronic obstructive pulmonary disease (COPD)
- asthma in adults aged 19 years and over
- asthma in children and young people aged under 19 years
- pneumonia
- bronchiolitis in children aged under 2 years
- the percentage of zero and one-day emergency admissions to hospital for pneumonia
- the percentage of zero and one-day emergency admissions to hospital for bronchiolitis in children aged under 2 years
Key messages:
- The rate of emergency admissions for respiratory disease in England increased by 1.0% from the financial year ending 2024 to the financial year ending 2025
- In the same time period, the rate of emergency admissions decreased for COPD by 3.6%, asthma in adults by 5.9% and bronchiolitis in children aged under 2 years by 5.0%
- The rate of emergency admissions for pneumonia in England remained similar to the previous year
Read the OHID statistics bulletin for a more detailed analysis and discussion of the hospital admissions.
Mortality
The mortality rate from all respiratory disease, for all ages and under 75s, has been updated with provisional mortality rates for 2025 and the 3-year period of 2023 to 2025.
Key messages
- The mortality rates from respiratory disease have decreased since 2001, with particularly large falls during the COVID-19 pandemic in 2020 and 2021. Rates have since increased and for both sexes, rates in 2025 were similar to 2024.
- For under-75s, the female mortality rate from respiratory disease in 2025 remained similar to 2024, but there was a small but significant decrease in the male rate.
- Compared with 2019, respiratory disease mortality rates were significantly lower in 2025. The male rate was 11% lower and the female rate 13% lower. For under-75s, the male rate was 5% lower and the female rate 6% lower.